Abzena is a startup based in the United Kingdom, most recent round Series-c-plus, 3 tracked investors.
Based in the United Kingdom, Abzena is a startup. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Abzena provides integrated services for the development of biopharmaceuticals, including antibody discovery, development, and manufacturing support for life sciences companies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.